A separate study by Li and colleagues found that Beta2-Microglobulin in glioma stem cells promoted an increased release of TGF-β1 from glioma cells via activation of the PI3K/AKT/MYC axis. This evidence concerns the gene AKT1 and central nervous system cancer.